Home / 2023

UK to ban Nitrous Oxide in plan to tackle anti-social behaviour

By |2023-03-28T11:54:29+01:003 February 2023|

Ministers are reportedly preparing to ban the sale and possession of laughing gas in England and Wales in an attempt to clamp down on antisocial behaviour.  The plan would likely place laughing gas, otherwise known as nitrous oxide, in the same drug classification as cannabis, resulting [...]

Comments Off on UK to ban Nitrous Oxide in plan to tackle anti-social behaviour

Does cannabis affect how we dream?

By |2023-03-28T11:54:56+01:003 February 2023|

We humans are fascinated by dreams. Think about it: how many times has someone struck up a conversation with you – whether a family member around the breakfast table or a colleague in the office – seemingly itching to tell you about their “weird” dream? Even [...]

Comments Off on Does cannabis affect how we dream?

Long-term cannabis use does not negatively impact health, Spanish study finds

By |2023-03-28T11:54:57+01:003 February 2023|

Results produced by a study that analysed data from 600,000 Spanish residents who regularly consumed cannabis indicate that long-term cannabis use does not contribute to the deterioration of health. Using indicators that were specifically designed to give an accurate picture of health, researchers analysed survey responses [...]

Comments Off on Long-term cannabis use does not negatively impact health, Spanish study finds

Can you give CBD to children?

By |2023-03-28T11:54:58+01:003 February 2023|

Rarely do questions of medical efficacy show up on the radar of public awareness. In most cases, the majority of us are quite happy to put trust in the hands of the experts. But every now and then, a trend is bucked, and a new phenomenon [...]

Comments Off on Can you give CBD to children?

Smoking cannabis not linked to high blood pressure finds study involving over 4500 people

By |2023-03-28T11:54:58+01:003 February 2023|

By examining data provided by 4565 people, researchers at the Northwestern University’s Feinberg School of Medicine in Chicago found no association between smoking cannabis and a higher likelihood of developing high blood pressure, otherwise known as hypertension. Data supplied by both cannabis users, who represented 19% [...]

Comments Off on Smoking cannabis not linked to high blood pressure finds study involving over 4500 people

How are consumers using CBD? 7 key trends in Europe

By |2023-02-03T03:06:37+00:003 February 2023|

A new report offers a hopeful picture of the current and future CBD landscape in Europe. We explore how, when, and why (or why not) people are using CBD products. CBD-infused products are popping up everywhere, from your local grocers to the high street pharmacy. The [...]

Comments Off on How are consumers using CBD? 7 key trends in Europe

New platform gives doctors tools to prescribe cannabis outside of specialist clinics

By |2023-02-03T03:06:18+00:003 February 2023|

A new online platform has been designed to overcome some of the issues preventing wider access to medical cannabis in the UK, by enabling doctors to prescribe independently of clinics.  Script Assist, which has been developed by the team at cannabis healthcare company, Sana Healthcare, aims [...]

Comments Off on New platform gives doctors tools to prescribe cannabis outside of specialist clinics

Malta’s cannabis club model to launch end of February – what you need to know

By |2023-02-03T03:06:01+00:003 February 2023|

Authorities in Malta have announced the details of its cannabis social club model, which is due to launch at the end of the month. Here’s everything you need to know. After an initial delay following the landmark legalisation of adult-use cannabis in 2021, the Maltese Authority [...]

Comments Off on Malta’s cannabis club model to launch end of February – what you need to know

Cannabis associated with long-term reduction in opioid use – study

By |2023-02-02T03:13:04+00:002 February 2023|

Medicinal cannabis was associated with a reduction in daily use of prescription opioids among chronic pain patients. A new study suggests that medical cannabis products were associated with substantial long-term decreases in the daily use of prescription opioids among patients living with chronic pain. With opioid-related [...]

Comments Off on Cannabis associated with long-term reduction in opioid use – study

NICE recommends Epidyolex for treatment of tuberous sclerosis complex

By |2023-02-02T03:12:39+00:002 February 2023|

The CBD-based drug, Epidyolex, will now be prescribed through the NHS for the treatment of seizures related to tuberous sclerosis complex (TSC). From 1 March 2023, patients living with TSC will have access to the cannabinoid-based treatment, Epidyolex, through the NHS, following a new recommendation from [...]

Comments Off on NICE recommends Epidyolex for treatment of tuberous sclerosis complex

Anticipating the Ebbs and Flows of Seasonal Retail Cannabis Sales

By |2023-02-01T03:30:40+00:001 February 2023|

Like any industry, cannabis can experience ups and downs, especially when it comes to a doors-open retail business. Dispensaries that operate in towns or cities that attract tourists experience this more than anyone, seeing sales spike during the busy months and reach lows during the off-season. [...]

Comments Off on Anticipating the Ebbs and Flows of Seasonal Retail Cannabis Sales

Transparency for cannabis pilot trials in Switzerland

By |2023-01-31T03:54:21+00:0031 January 2023|

For the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the country’s Weed Care study within the Swiss pilot projects will be able to purchase cannabis in pharmacies in Basel.  The Swiss company Vigia AG has developed the Cannabis [...]

Comments Off on Transparency for cannabis pilot trials in Switzerland

Legalising cannabis does not increase substance misuse, finds study

By |2023-01-31T03:54:09+00:0031 January 2023|

New research refutes the theory that cannabis is a ‘gateway drug’, finding no increase in substance use disorders or psychological problems in states which have legalised adult-use.  The research from CU Boulder in the US, found that the legalisation of adult-use cannabis at the state level [...]

Comments Off on Legalising cannabis does not increase substance misuse, finds study

3 Benefits of Conducting Genetic Tests on Your Plants

By |2023-01-31T03:53:59+00:0031 January 2023|

Many growers may wonder why it’s important to get their plants genetically tested, but the truth is that genetic testing can make growing a lot easier. Genetic analysis in plants can give a wide range of results that can help scientists solve everyday problems in plant [...]

Comments Off on 3 Benefits of Conducting Genetic Tests on Your Plants

Four of the best CBD flower and tea brands

By |2023-01-28T03:09:26+00:0028 January 2023|

CBD flower exists in a regulatory grey area across Europe, but for many people it is their preferred method of cannabinoid consumption, whether vaporised or steeped in water and drank as tea. CBD has kind of outdone every other cannabinoid in the cannabis plant, in terms [...]

Comments Off on Four of the best CBD flower and tea brands

Satanic herbs and royal medicine: a (brief) history of cannabis in the UK

By |2023-01-28T03:09:07+00:0028 January 2023|

Whether for fibre, food or medicine, cannabis has been a part of life for thousands of years. The stigma around it, however, is relatively new. Read on for an overview of the history of cannabis in the UK. Humans and cannabis have had a symbiotic relationship [...]

Comments Off on Satanic herbs and royal medicine: a (brief) history of cannabis in the UK

Cannabis policy and psychosis – study finds no increase in rates of diagnosis

By |2023-01-27T03:41:41+00:0027 January 2023|

A new study has found no significant increase in the rates of psychosis-related diagnoses in states which have introduced cannabis policies. Researchers from the Hospital of the University of Pennsylvania in Philadelphia found no ‘statistically significant difference’ in the rates of psychosis-related diagnoses, or prescribed antipsychotics, [...]

Comments Off on Cannabis policy and psychosis – study finds no increase in rates of diagnosis

Czech Republic to outline laws for legalisation of adult-use cannabis

By |2023-01-27T03:41:30+00:0027 January 2023|

Proposals for the legalisation of adult-use cannabis in the Czech Republic are expected to be published in a matter of months with a focus on ‘reform, regulation and taxation’.  Draft laws, which would see the introduction of a regulated cannabis market in the Czech Republic, could [...]

Comments Off on Czech Republic to outline laws for legalisation of adult-use cannabis

The Grocer Awards recognise CBD Patches by BRITISH CANNABIS™

By |2023-01-26T03:04:08+00:0026 January 2023|

The Grocer Awards 2022 included CBD by BRITISH CANNABIS Dermal Patches as one of the ‘New Products of The Year’. The Rising New Product was selected to join a shortlist of finalists in the Personal Care Category at the annual event at the Hilton Bankside, London, [...]

Comments Off on The Grocer Awards recognise CBD Patches by BRITISH CANNABIS™

NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case

By |2023-01-26T03:03:47+00:0026 January 2023|

The NHS has reimbursed the cost of a UK patient’s private medicinal cannabis treatment, in what has been described as a ‘rare’ case.  A patient at Zerenia Clinics has successfully attained full reimbursement of the costs of unlicensed cannabis-based medication and clinic fees through the NHS.  [...]

Comments Off on NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case

AOAC International Names New CSO

By |2023-01-26T03:02:59+00:0026 January 2023|

AOAC International, an independent nonprofit standards development organization has announced the appointment of Dr. Katerina (Kate) Mastovska as their new deputy executive director and chief science officer. Dr. Katerina Mastovska Most recently, Dr. Mastovska served as chief science officer for the Eurofins US Food Division. She [...]

Comments Off on AOAC International Names New CSO

Could medical cannabis play a role in treating substance misuse?

By |2023-01-25T03:25:02+00:0025 January 2023|

Dr Nat Wright, clinical advisor to European cannabis company AltoVerde, discusses how cannabis can play an important role in treating substance misuse and in alleviating the over-prescription of opioids. Medical cannabis became legal in the UK in 2018 and in the four years since, the number [...]

Comments Off on Could medical cannabis play a role in treating substance misuse?

Cannabis shows promise as treatment for borderline personality disorder (BPD)

By |2023-01-25T03:24:40+00:0025 January 2023|

The first research of its kind has reported ‘promising’ findings in the treatment of borderline personality disorder (BPD) with cannabinoids.  When used in a controlled clinical environment, cannabis-based medicines can lead to a ‘substantial improvement’ in symptoms associated with BPD, also known as emotionally unstable personality [...]

Comments Off on Cannabis shows promise as treatment for borderline personality disorder (BPD)

Attracting Investment: How Cannabis Companies Can Best Position Themselves

By |2023-01-25T03:24:32+00:0025 January 2023|

Remember those heady days of the Green Rush a decade ago, when markets were small and it seemed everyone had a chance? Now it’s more of a mad rush to get some green in the form of investment capital. The majority of states in the country [...]

Comments Off on Attracting Investment: How Cannabis Companies Can Best Position Themselves

UK’s Medical Cannabis Industry Enjoys Strong Start To 2023

By |2023-01-24T03:14:47+00:0024 January 2023|

LAST week a flurry of positive announcements from across the UK’s medical cannabis industry were unveiled in signs the industry is wasting no time in shaking off the stagnation of 2022.  Firstly, new data published by the government has provided the latest insight into the size [...]

Comments Off on UK’s Medical Cannabis Industry Enjoys Strong Start To 2023

ACCESS CBD voted UK’s best CBD oil in pharmacy sector for sleep, stress and insomnia

By |2023-01-24T03:14:02+00:0024 January 2023|

BRITISH CANNABIS brand ACCESS CBD® was voted Best CBD Oil in Pharmacy for the second time, with CBD by BRITISH CANNABIS CBD Oils and Dermal Patches shortlisted for a further three categories.  The MVP Pharmacy Awards took place in November 2022 at a prestigious London venue [...]

Comments Off on ACCESS CBD voted UK’s best CBD oil in pharmacy sector for sleep, stress and insomnia

Access to adult-use cannabis reduced demand for prescription codeine – study

By |2023-01-24T03:13:38+00:0024 January 2023|

US states which have legalised adult-use cannabis have seen a reduction in demand for prescription codeine, according to a new study.  Published this week in Health Economics, a multi-institutional study led by University of Pittsburgh and Cornell University scientists, finds a significant reduction in pharmacy-based codeine [...]

Comments Off on Access to adult-use cannabis reduced demand for prescription codeine – study

A Guide to Dispensary Insurance

By |2023-01-24T03:13:31+00:0024 January 2023|

As a business owner, insurance is always a must. If you are interested in entering into the cannabis industry or you already have, it’s important to know what to expect when it comes to insuring your cannabis-related business. That’s why we’ll be exploring what dispensary insurance [...]

Comments Off on A Guide to Dispensary Insurance

One in five taking part in Dry January turn to cannabis instead – survey

By |2023-01-22T04:30:45+00:0022 January 2023|

One in five people taking part in Dry January are substituting alcohol for cannabis, a new survey from the US shows.  Dry January has become increasingly popular in recent years, as consumers attempt to ditch the drink throughout the first month of the year, following the [...]

Comments Off on One in five taking part in Dry January turn to cannabis instead – survey

UK patient registry to continue for fourth year with key changes

By |2023-01-22T04:30:14+00:0022 January 2023|

Drug Science has announced that its cannabis patient registry, Project Twenty21, will continue collecting data for a fourth year with new partners on board. The UK charity for drug reform confirmed this week that its medicinal cannabis patient registry, formerly known as Project Twenty21, will continue [...]

Comments Off on UK patient registry to continue for fourth year with key changes

Cruelty-free CBD: cannabis-based beauty products that are vegan-friendly

By |2023-01-20T03:02:30+00:0020 January 2023|

Whether you’re vegan-for-life or celebrating Veganuary, we’ve sought out some CBD-based beauty products that can help give you a cruelty-free cannabis glow-up. The start of a new year often goes hand in hand with resolutions, new routines and dreams of rejuvenation. It also happens to align [...]

Comments Off on Cruelty-free CBD: cannabis-based beauty products that are vegan-friendly

Linnea SA to produce medicinal cannabis in Switzerland 

By |2023-01-20T03:02:15+00:0020 January 2023|

Pharmaceutical manufacturer, Linnea SA, has been granted a licence for the production of high-THC medicinal cannabis products in Switzerland. Linnea SA was granted a narcotics licence by Swissmedic at the end of 2022, making it one of the first companies in Switzerland to be able to [...]

Comments Off on Linnea SA to produce medicinal cannabis in Switzerland 

Cost analysis of cannabis on the NHS to launch next month

By |2023-01-20T03:01:55+00:0020 January 2023|

A new project, designed to show how cannabis would be cost-effective on the NHS, is due to get underway next month. Experts at York Health Economics Consortium are to develop a flexible health economics analysis tool to evaluate the feasibility of prescribing cannabis on the NHS.  [...]

Comments Off on Cost analysis of cannabis on the NHS to launch next month

Linnea SA Receives Swiss Narcotics License Allowing For The Production And Exportation Of High THC Active Pharmaceutical Ingredients

By |2023-01-19T03:05:20+00:0019 January 2023|

LINNEA SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics license by Swissmedic at the end of 2022. They are now one of the first companies in Switzerland to be able to produce and export high THC [...]

Comments Off on Linnea SA Receives Swiss Narcotics License Allowing For The Production And Exportation Of High THC Active Pharmaceutical Ingredients

Kanabo Launches 2 New High-THC Vape Formulas As It Prepares To Compete On ‘Patient Care’ In 2023

By |2023-01-19T03:05:13+00:0019 January 2023|

KANABO announced the launch of two new additions to its range of VapePod formulas this week, in what is expected to be the first in a flurry of announcements due in the coming months.  The launch of two new high-THC formulas, which represent the second generation [...]

Comments Off on Kanabo Launches 2 New High-THC Vape Formulas As It Prepares To Compete On ‘Patient Care’ In 2023

Bedrocan to manufacture cannabis products in Denmark

By |2023-01-19T03:04:43+00:0019 January 2023|

The Dutch producer of medicinal cannabis is to open a new facility in Denmark in order to meet demand from patients across Europe.  Bedrocan, the sole producer of medicinal cannabis in the Netherlands since 2003, has announced it will establish a new facility to manufacture its [...]

Comments Off on Bedrocan to manufacture cannabis products in Denmark

Dr Sandra Carrillo: exploring medicinal cannabis in Colombia

By |2023-01-19T03:04:05+00:0019 January 2023|

The Colombian government recently confirmed that cannabis medicines would be covered by the healthcare system, making it one of the few countries in the world to introduce such a policy.  Dr Sandra Carrillo, of the Colombian Medical Cannabis Association, tells Cannabis Health how attitudes are finally [...]

Comments Off on Dr Sandra Carrillo: exploring medicinal cannabis in Colombia

Compliance as a Revenue Center: Banking & Cannabis, More Similar Than You Think

By |2023-01-19T03:03:57+00:0019 January 2023|

Have you ever been to the DMV, only to be turned away because you didn’t have the countless forms of identification needed? Sometimes it feels like no amount of ID or proof of residence is enough, whether it’s your 2nd grade report card or an electric [...]

Comments Off on Compliance as a Revenue Center: Banking & Cannabis, More Similar Than You Think

Data: The Key to Success in Today’s Cannabis Market

By |2023-01-19T03:03:54+00:0019 January 2023|

As the cannabis industry continues to evolve, recent market challenges have created an environment that is more difficult for industry leaders to navigate. To find success in today’s marketplace, company leaders need to adopt a robust, data-driven approach to combat the influx of rising brands, emerging [...]

Comments Off on Data: The Key to Success in Today’s Cannabis Market

Regular cannabis consumption has no negative impact on public health – study

By |2023-01-18T03:05:58+00:0018 January 2023|

A new study from researchers in Spain found no decline in the health of regular cannabis consumers when compared to the general population. The paper, published in the journal Cannabis and Cannabinoid Research, assessed the impact of regular cannabis consumption on public health and compared the [...]

Comments Off on Regular cannabis consumption has no negative impact on public health – study

Over 89,000 private cannabis prescriptions since 2018, fewer than five on the NHS

By |2023-01-18T03:05:26+00:0018 January 2023|

The legalisation of cannabis on prescription has failed to deliver access for all, say advocates, as new figures reveal the growing gap between private and NHS prescribing.   New data has revealed the number of private and NHS cannabis prescriptions issued in England since the law change [...]

Comments Off on Over 89,000 private cannabis prescriptions since 2018, fewer than five on the NHS

Can cannabis help your mental health? Everything you need to know

By |2023-01-17T03:42:37+00:0017 January 2023|

With the prevalence of poor mental health on the rise, many people are finding cannabis helpful for managing symptoms of common disorders such as depression, anxiety and PTSD. We explore its role in mental health treatment in more detail.  All of us have ‘mental health’ – [...]

Comments Off on Can cannabis help your mental health? Everything you need to know

UK Medical Cannabis Registry – what does the latest data say?

By |2023-01-17T03:41:59+00:0017 January 2023|

Three new research studies have been published using data from the UK Medical Cannabis Registry that demonstrate the effects of cannabis in those living with depression, childhood epilepsy and inflammatory bowel disease (IBD). The Registry, which is run by Sapphire Medical Clinics, is thought to be [...]

Comments Off on UK Medical Cannabis Registry – what does the latest data say?

Nature’s medicine: could cannabis be key in the fight for climate and biodiversity?

By |2023-01-14T03:04:00+00:0014 January 2023|

After decades of negotiations, almost 200 countries have agreed to a historic deal to halt and reverse biodiversity loss by 2030. Cannabis could help get them to the goal while slashing carbon emissions in the process. Planetary health is human health, and the twin challenges of [...]

Comments Off on Nature’s medicine: could cannabis be key in the fight for climate and biodiversity?

Italian Army Pledges To More Than Double Medical Cannabis Production This Year, But Supply Issues Far From Over

By |2023-01-13T03:17:29+00:0013 January 2023|

THE Italian army, which continues to hold a monopoly over medical cannabis production, has announced plans to dramatically ramp up production this year.  On December 30, 2022, General Manager of the Defence Industries Agency Nicola Latorre announced in an interview with Defense World that the army [...]

Comments Off on Italian Army Pledges To More Than Double Medical Cannabis Production This Year, But Supply Issues Far From Over

Latest cannabis research: five new studies to know about

By |2023-01-13T03:16:54+00:0013 January 2023|

In recent weeks, promising research has been published on the potential of cannabis as a tool for sleep, muscle recovery, multiple sclerosis (MS) and inflammatory bowel disease (IBD). With a record number of research papers published on cannabis and its therapeutic potential in 2022, it can [...]

Comments Off on Latest cannabis research: five new studies to know about

UK company granted approval for clinical trial of synthetic CBD on sleep

By |2023-01-13T03:16:19+00:0013 January 2023|

UK company, Chanelle McCoy Health, has been granted ethics approval in Australia for a clinical trial investigating the effect of its synthetic CBD formulation on sleep. The pharmaceutical company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia, for a significant Phase III [...]

Comments Off on UK company granted approval for clinical trial of synthetic CBD on sleep

Spain Misses Ambitious Medical Cannabis Roll Out Targets As Government Remains Tight-Lipped On Progress

By |2023-01-12T03:11:24+00:0012 January 2023|

SPAIN’s ambitious plans to see the regulation and distribution of medical cannabis rolled out across the country by the end of 2022 appear to have been delayed.  December 27, 2022 marked the deadline for the Spanish Agency for Medicines and Health Products (AEMPS) to ensure proposals, [...]

Comments Off on Spain Misses Ambitious Medical Cannabis Roll Out Targets As Government Remains Tight-Lipped On Progress

US study finds rise in cannabis-related hospital visits among older people

By |2023-01-12T03:10:38+00:0012 January 2023|

New findings highlighting a rise in cannabis-related hospital visits among older consumers have led to calls for more patient-doctor communication around its use in medical care.  As a growing number of older adults are experimenting with cannabis to help alleviate chronic symptoms, a new study has [...]

Comments Off on US study finds rise in cannabis-related hospital visits among older people